Первый в США пациент вылечил хроническую боль в спине с помощью фокусированного ультразвука

Newswise — In this episode of Curing with Sound, we speak with Jim Rorie, a licensed private investigator from North Carolina whose career and daily life were profoundly affected by chronic low back pain following a multi-vehicle collision. After months of physical therapy and painful nerve block injections, Jim became one of the first patients in the United States to be commercially treated with noninvasive focused ultrasound for his back pain. He shares what led him to the procedure, what the treatment experience was like, and how it has transformed his pain, his work, and his quality of life. Discussion highlights: - First-of-its-Kind Device Receives FDA Clearance: In November 2025, the FUSMobile Neurolyser XR system received De Novo clearance from the US Food and Drug Administration (FDA) for the treatment of chronic low back pain. The device, which uses focused ultrasound to ablate sensory nerves in the spinal facet joints, is also approved in Europe, Canada, and the UK. - Renewed Hope and Quality of Life: Jim reflects on the difference focused ultrasound has made in his recovery, allowing him to return to his career as a private investigator and regain activities that chronic pain had previously limited.